{"id":"https://genegraph.clinicalgenome.org/r/1c3fa8dc-147d-4c56-9578-1294fbd5ec17v2.0","type":"EvidenceStrengthAssertion","dc:description":"The SLC52A2 gene has been associated with autosomal recessive Brown-Vialetto-Van Laere syndrome using the ClinGen Clinical Validity Framework as of 9/12/2017. This association was made using case-level data only. At least 12 missense and nonsense variants have been reported in humans. SLC52A2 was first associated with this disease in humans as early as 2012 (Johnson et al.). SLC52A2 is associated with the childhood onset neurodegenerative syndrome Brown–Vialetto–Van Laere (BVVL) which is characterized by sensorineural hearing loss and ponto-bulbar palsy (PMID: 22864630, 30420458). Whilst these are the most common clinical features, BVVL can also present without either symptom (PMID: 26973221). The standard treatment for BVVL is riboflavin supplementation which is associated with favourable clinical outcomes (PMID: 26973221). 10 probands in 7 publications (22740598, 22864630, 23243084, 24616084, 24253200, 25807286, 29053833) are included in this curation. Variants in this gene segregated with disease in 5 additional family members. More evidence is available in the literature, but the maximum score for genetic evidence and/or experimental evidence (12 pts.) has been reached. This gene-disease association is supported by expression studies and in vitro assays. In summary, SLC52A2 is definitively associated with autosomal recessive Brown-Vialetto-Van Laere syndrome. \n\nThis gene-disease pair was originally evaluated by the ClinGen Hearing Loss GCEP on 7/9/2018. It was reevaluated on 6/21/2023 in collaboration with the Amyotrophic Lateral Sclerosis Spectrum Disorders GCEP. As a result of this reevaluation, the classification did not change. However additional genetic evidence has been included and scoring adjusted to the current Gene Clinical Validity SOP Version 9. The new genetic evidence included 8 variants (5 missense, 1 frameshift, 1 nonsense, 1 small deletion) and 6 probands in 6 publications (PMID: 31064337, 30343981, 29961509, 29053833, 34737166, 27148561).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1c3fa8dc-147d-4c56-9578-1294fbd5ec17","GCISnapshot":"https://genegraph.clinicalgenome.org/r/5a500078-4cd5-49db-b22e-c5628ee07304","calculatedEvidenceStrength":"Definitive","changes":[{"id":"cg:newEvidence"},{"id":"cg:sopChange"},{"id":"cg:summaryChange"},{"id":"cg:otherTextChange"}],"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/5a500078-4cd5-49db-b22e-c5628ee07304_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2023-10-10T14:38:08.843Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/5a500078-4cd5-49db-b22e-c5628ee07304_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2023-09-04T16:00:00.000Z","role":"Approver"},{"agent":"https://genegraph.clinicalgenome.org/agent/10096","role":"SecondaryContributor"}],"curationReasons":["RecurationTiming"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a500078-4cd5-49db-b22e-c5628ee07304_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85e9b3ff-6a98-499c-bd1c-b7c876b493ed_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/85e9b3ff-6a98-499c-bd1c-b7c876b493ed","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27148561","rdfs:label":"Petrovski Proband","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":15,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/beeeeafc-4d55-436c-bda0-3d76afb62406","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.808C>T (p.Gln270Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA198667"}},{"id":"https://genegraph.clinicalgenome.org/r/14a4e565-1a6c-427e-8924-6c48b8a577c1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.1016T>C (p.Leu339Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343794"}}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Excessive drooling","phenotypes":["obo:HP_0002378","obo:HP_0010544","obo:HP_0002317"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/2eb9acc8-eeb4-4596-bd4e-74007927924e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27148561","allele":{"id":"https://genegraph.clinicalgenome.org/r/14a4e565-1a6c-427e-8924-6c48b8a577c1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/43da87c1-62fd-43cc-b226-b3af33c94c2b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27148561","allele":{"id":"https://genegraph.clinicalgenome.org/r/beeeeafc-4d55-436c-bda0-3d76afb62406"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/2eb9acc8-eeb4-4596-bd4e-74007927924e","type":"EvidenceLine","dc:description":"Recurrent variant previously scored","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2eb9acc8-eeb4-4596-bd4e-74007927924e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/43da87c1-62fd-43cc-b226-b3af33c94c2b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43da87c1-62fd-43cc-b226-b3af33c94c2b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1e9c8e80-1957-4d7b-834f-e7ff561ba447_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e9c8e80-1957-4d7b-834f-e7ff561ba447","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22740598","rdfs:label":"Johnson Proband","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3708cf89-2ed4-4628-afe6-6051a1d3faaa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.916G>A (p.Gly306Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA342818"}},"detectionMethod":"SNP genotyping, autozygosity mapping, exome sequencing, Sanger sequencing","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000408","obo:HP_0008936","obo:HP_0001308","obo:HP_0002483"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d2a80cdd-4074-4c16-9257-6b386c1b4d43_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22740598","allele":{"id":"https://genegraph.clinicalgenome.org/r/3708cf89-2ed4-4628-afe6-6051a1d3faaa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/d2a80cdd-4074-4c16-9257-6b386c1b4d43","type":"EvidenceLine","dc:description":"Upgraded by 0.4pts for founder variant","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2a80cdd-4074-4c16-9257-6b386c1b4d43_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d2a80cdd-4074-4c16-9257-6b386c1b4d43_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"3 H-Riboflavin uptake assay demonstrated decreased 3 H-riboflavin transport activity by mutated SLC52A2 compared to wild-type (Foley et al 2014, PMID: 24253200).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/90916b02-6e9e-4f5b-a95a-c114c19f6aba_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90916b02-6e9e-4f5b-a95a-c114c19f6aba","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","rdfs:label":"AM5","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/b1684f9f-994b-4dc0-9122-e82567b81c3d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.1327T>C (p.Cys443Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372630521"}},"detectionMethod":"screened for SLC52A2, SLC52A1 and SLC52A3 variants","ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypes":["obo:HP_0000639","obo:HP_0000648","obo:HP_0000407"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8e35e67b-17b2-4978-bcb2-46a7e2d42eef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/b1684f9f-994b-4dc0-9122-e82567b81c3d"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/8e35e67b-17b2-4978-bcb2-46a7e2d42eef","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e35e67b-17b2-4978-bcb2-46a7e2d42eef_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/448e5cb1-9844-4a14-b088-75163e306cea_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/448e5cb1-9844-4a14-b088-75163e306cea","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23243084","rdfs:label":"Ciccolella Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/19d7b7ba-7d12-4675-8148-46f78d4b332a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.155C>T (p.Ser52Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/40231"}},{"id":"https://genegraph.clinicalgenome.org/r/55d3431c-b17b-49d0-a983-251e13d6e5cc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.1255G>A (p.Gly419Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/40232"}}],"detectionMethod":"Screened for SLC52A1, SLC52A3 and SLC52A2 variants","firstTestingMethod":"PCR","phenotypes":["obo:HP_0002878","obo:HP_0003327","obo:HP_0011951","obo:HP_0000408","obo:HP_0002747","obo:HP_0001618"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/52e4b7dc-cf30-43a4-b14c-d1c7f7854de3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23243084","allele":{"id":"https://genegraph.clinicalgenome.org/r/19d7b7ba-7d12-4675-8148-46f78d4b332a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/5e5ed01a-45fa-4e7e-8222-d0207617192e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23243084","allele":{"id":"https://genegraph.clinicalgenome.org/r/55d3431c-b17b-49d0-a983-251e13d6e5cc"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/5e5ed01a-45fa-4e7e-8222-d0207617192e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e5ed01a-45fa-4e7e-8222-d0207617192e_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/52e4b7dc-cf30-43a4-b14c-d1c7f7854de3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52e4b7dc-cf30-43a4-b14c-d1c7f7854de3_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/52e4b7dc-cf30-43a4-b14c-d1c7f7854de3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"3 H-Riboflavin uptake assay demonstrated decreased 3 H-riboflavin transport activity by mutated SLC52A2 compared to wild-type (Console et al., 2021, PMID: 34428344).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/c5354931-c65d-473f-9029-a8f2213d6203_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5354931-c65d-473f-9029-a8f2213d6203","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24253200","rdfs:label":"E2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":6,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/260736e9-b24f-444b-aa35-7b60b9b63785","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.92G>C (p.Trp31Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/210037"}},{"id":"https://genegraph.clinicalgenome.org/r/84639304-886f-420a-bb08-c522addd961a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.935T>C (p.Leu312Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/210041"}}],"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0000648","obo:HP_0001324","obo:HP_0002066","obo:HP_0000407","obo:HP_0007141"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d4ce48a8-ae82-48cf-b68f-0cfd053509cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24253200","allele":{"id":"https://genegraph.clinicalgenome.org/r/260736e9-b24f-444b-aa35-7b60b9b63785"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/f9bd952c-c7c8-4615-9856-03227c57b4eb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24253200","allele":{"id":"https://genegraph.clinicalgenome.org/r/84639304-886f-420a-bb08-c522addd961a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/f9bd952c-c7c8-4615-9856-03227c57b4eb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9bd952c-c7c8-4615-9856-03227c57b4eb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/f9bd952c-c7c8-4615-9856-03227c57b4eb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"3 H-Riboflavin uptake assay demonstrated decreased 3 H-riboflavin transport activity by mutated SLC52A2 compared to wild-type (Foley et al 2014, PMID: 24253200).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d4ce48a8-ae82-48cf-b68f-0cfd053509cd","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4ce48a8-ae82-48cf-b68f-0cfd053509cd_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d4ce48a8-ae82-48cf-b68f-0cfd053509cd_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"3 H-Riboflavin uptake assay demonstrated decreased 3 H-riboflavin transport activity by mutated SLC52A2 compared to wild-type (Foley et al 2014, PMID: 24253200).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/6e532b74-e274-4e93-abdd-0b28ab81eaf8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e532b74-e274-4e93-abdd-0b28ab81eaf8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22864630","rdfs:label":"Haack Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/ecc49805-586c-4228-9792-f05407848ce8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.368T>C (p.Leu123Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/39576"}},{"id":"https://genegraph.clinicalgenome.org/r/14a4e565-1a6c-427e-8924-6c48b8a577c1"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000408","obo:HP_0003477","obo:HP_0007221","obo:HP_0001308","obo:HP_0010544","obo:HP_0000648"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/935bcf94-874e-41bb-ba0f-9017a4487451_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22864630","allele":{"id":"https://genegraph.clinicalgenome.org/r/ecc49805-586c-4228-9792-f05407848ce8"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/b10f6bed-e096-4a57-84f5-60bc3481c0d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22864630","allele":{"id":"https://genegraph.clinicalgenome.org/r/14a4e565-1a6c-427e-8924-6c48b8a577c1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/b10f6bed-e096-4a57-84f5-60bc3481c0d2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b10f6bed-e096-4a57-84f5-60bc3481c0d2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b10f6bed-e096-4a57-84f5-60bc3481c0d2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Riboflavin uptake was assessed in HEK-293 cells. Riboflavin uptake was ~250 fmol/mg less than wildtype","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/935bcf94-874e-41bb-ba0f-9017a4487451","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/935bcf94-874e-41bb-ba0f-9017a4487451_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/935bcf94-874e-41bb-ba0f-9017a4487451_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Riboflavin uptake was assessed in HEK-293 cells. Riboflavin uptake was ~250 fmol/mg less than wildtype","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/6101a17a-14d1-4308-99af-05d981d58983_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6101a17a-14d1-4308-99af-05d981d58983","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34737166","rdfs:label":"Liu Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/e03b58cf-2c09-44ab-b702-9bfac0d7203a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.350T>C (p.Leu117Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372626925"}},{"id":"https://genegraph.clinicalgenome.org/r/45b6ef74-bcfe-4931-94d7-8ff8999be3ce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.1135_1137del (p.Trp379del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2580617389"}}],"detectionMethod":"Gene panel (927 genes associated with neuromuscular disorders).  \n\n","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"reduced muscle tone, spine scoliosis\n","phenotypes":["obo:HP_0001897","obo:HP_0000519"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f7f0990d-c994-4265-bf76-e4f707c81c5b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34737166","allele":{"id":"https://genegraph.clinicalgenome.org/r/e03b58cf-2c09-44ab-b702-9bfac0d7203a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/e05da3e9-fbd1-4626-b380-2f3ba71a075b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34737166","allele":{"id":"https://genegraph.clinicalgenome.org/r/45b6ef74-bcfe-4931-94d7-8ff8999be3ce"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/f7f0990d-c994-4265-bf76-e4f707c81c5b","type":"EvidenceLine","dc:description":" ","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7f0990d-c994-4265-bf76-e4f707c81c5b_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/e05da3e9-fbd1-4626-b380-2f3ba71a075b","type":"EvidenceLine","dc:description":"In the last exon so expected to escape NMD.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e05da3e9-fbd1-4626-b380-2f3ba71a075b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/59dc52e6-bfac-4176-813e-d5f75202b871_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/59dc52e6-bfac-4176-813e-d5f75202b871","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","rdfs:label":"AM3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/d1f6d8a3-f08b-4d88-a3e9-36b1358b6513","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.863C>T (p.Ala288Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4938295"}},{"id":"https://genegraph.clinicalgenome.org/r/81fa9bf3-4796-48f9-95d9-77b19e5b8a66","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.229G>A (p.Glu77Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4938149"}}],"detectionMethod":"PCR and sanger sequencing of SLC52A2, SLC52A1 and SLC52A3 \n","firstTestingMethod":"PCR","phenotypeFreeText":"Upper limb and lower limb weakness, breathing difficulty","phenotypes":["obo:HP_0000648","obo:HP_0000365"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/53f253e0-2a25-4fe5-8243-cd62c10a1919_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/d1f6d8a3-f08b-4d88-a3e9-36b1358b6513"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/9fbb0e7a-263b-4dbe-b822-993dac0a6102_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/81fa9bf3-4796-48f9-95d9-77b19e5b8a66"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/9fbb0e7a-263b-4dbe-b822-993dac0a6102","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9fbb0e7a-263b-4dbe-b822-993dac0a6102_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/53f253e0-2a25-4fe5-8243-cd62c10a1919","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53f253e0-2a25-4fe5-8243-cd62c10a1919_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/b08c0b2a-161b-44c0-b086-e14053d1dbc6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b08c0b2a-161b-44c0-b086-e14053d1dbc6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25807286","rdfs:label":"Family 1 Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":21,"allele":{"id":"https://genegraph.clinicalgenome.org/r/14a4e565-1a6c-427e-8924-6c48b8a577c1"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0002795","obo:HP_0000572","obo:HP_0002066","obo:HP_0000407"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/b60629b8-dbb1-4c84-abb4-33f891d2f7d0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25807286","allele":{"id":"https://genegraph.clinicalgenome.org/r/14a4e565-1a6c-427e-8924-6c48b8a577c1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/b60629b8-dbb1-4c84-abb4-33f891d2f7d0","type":"EvidenceLine","dc:description":"Recurrent variant that has already been scored.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b60629b8-dbb1-4c84-abb4-33f891d2f7d0_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b60629b8-dbb1-4c84-abb4-33f891d2f7d0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"3 H-Riboflavin uptake assay demonstrated decreased 3 H-riboflavin transport activity by mutated SLC52A2 compared to wild-type (Foley et al 2014, PMID: 24253200).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/66470139-7aa1-4a9b-806b-aad8a27eabc5_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/66470139-7aa1-4a9b-806b-aad8a27eabc5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24616084","rdfs:label":"Srour Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/3708cf89-2ed4-4628-afe6-6051a1d3faaa"},"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a2217a96-3386-4d80-9db3-6c80be1e9b55_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24616084","allele":{"id":"https://genegraph.clinicalgenome.org/r/3708cf89-2ed4-4628-afe6-6051a1d3faaa"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/a2217a96-3386-4d80-9db3-6c80be1e9b55","type":"EvidenceLine","dc:description":"Recurrent variant that has already been scored.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a2217a96-3386-4d80-9db3-6c80be1e9b55_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a2217a96-3386-4d80-9db3-6c80be1e9b55_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"3 H-Riboflavin uptake assay demonstrated decreased 3 H-riboflavin transport activity by mutated SLC52A2 compared to wild-type (Foley et al 2014, PMID: 24253200).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/eefb6b1e-6206-40cf-81fc-f0a7ef271799_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eefb6b1e-6206-40cf-81fc-f0a7ef271799","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24253200","rdfs:label":"E3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":5,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/85214752-09a6-4a72-8d59-7a8c9ef7fe93","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.700C>T (p.Gln234Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/210039"}},{"id":"https://genegraph.clinicalgenome.org/r/2042e3a5-f23b-410d-86c2-90fb66820d30","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.1258G>A (p.Ala420Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/210043"}}],"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001324","obo:HP_0000407","obo:HP_0007141","obo:HP_0002066","obo:HP_0000648"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/d63b6ddf-0f7f-4491-9cdb-01de1b81104c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24253200","allele":{"id":"https://genegraph.clinicalgenome.org/r/85214752-09a6-4a72-8d59-7a8c9ef7fe93"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/da3352e7-580a-4202-bd2b-9eeb52295cd4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24253200","allele":{"id":"https://genegraph.clinicalgenome.org/r/2042e3a5-f23b-410d-86c2-90fb66820d30"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/d63b6ddf-0f7f-4491-9cdb-01de1b81104c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d63b6ddf-0f7f-4491-9cdb-01de1b81104c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d63b6ddf-0f7f-4491-9cdb-01de1b81104c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"3 H-Riboflavin uptake assay demonstrated decreased 3 H-riboflavin transport activity by mutated SLC52A2 compared to wild-type (Foley et al 2014, PMID: 24253200).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/da3352e7-580a-4202-bd2b-9eeb52295cd4","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/da3352e7-580a-4202-bd2b-9eeb52295cd4_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.1},{"id":"https://genegraph.clinicalgenome.org/r/5a500078-4cd5-49db-b22e-c5628ee07304_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c9bf21a-6332-4ace-b10d-6378445e1f60_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25807286","rdfs:label":"Family 1","estimatedLodScore":0.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/7c9bf21a-6332-4ace-b10d-6378445e1f60","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/b08c0b2a-161b-44c0-b086-e14053d1dbc6"}},"meetsInclusionCriteria":false,"phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0002795","obo:HP_0002066","obo:HP_0000407","obo:HP_0000572"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/b08c0b2a-161b-44c0-b086-e14053d1dbc6"}},{"id":"https://genegraph.clinicalgenome.org/r/6fba43dd-e6f5-42fc-85f2-59a915c9062a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24616084","rdfs:label":"Srour Family","estimatedLodScore":3.91,"family":{"id":"https://genegraph.clinicalgenome.org/r/6fba43dd-e6f5-42fc-85f2-59a915c9062a","type":"Family","rdfs:label":"Srour Family","member":{"id":"https://genegraph.clinicalgenome.org/r/66470139-7aa1-4a9b-806b-aad8a27eabc5"}},"meetsInclusionCriteria":true,"phenotypeNegativeAlleleNegative":12,"phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0002650","obo:HP_0000408","obo:HP_0001284","obo:HP_0003690","obo:HP_0002066"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/66470139-7aa1-4a9b-806b-aad8a27eabc5"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d6b894a6-375c-4f9b-9fe9-578bc3d846b3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6b894a6-375c-4f9b-9fe9-578bc3d846b3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","rdfs:label":"AP2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/5f13f7c6-9bed-4e91-8789-f9c4cd0a37e4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.383C>T (p.Ser128Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/210038"}},{"id":"https://genegraph.clinicalgenome.org/r/3ea4a791-5fb6-4723-b85b-8b4fc9a86cc4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.1088C>T (p.Pro363Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/210042"}}],"detectionMethod":"screened for SLC52A2, SLC52A1 and SLC52A3 variants","phenotypes":["obo:HP_0007141","obo:HP_0011474","obo:HP_0000648"],"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/9ef9480e-f6c0-4f41-9ca9-a4ed5840df53_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/5f13f7c6-9bed-4e91-8789-f9c4cd0a37e4"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/21d10623-6a6e-4760-a206-40894c7c0b1a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/3ea4a791-5fb6-4723-b85b-8b4fc9a86cc4"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/9ef9480e-f6c0-4f41-9ca9-a4ed5840df53","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ef9480e-f6c0-4f41-9ca9-a4ed5840df53_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9ef9480e-f6c0-4f41-9ca9-a4ed5840df53_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"3 H-Riboflavin uptake assay demonstrated decreased 3 H-riboflavin transport activity by mutated SLC52A2 compared to wild-type (Console et al., 2021, PMID: 34428344).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/21d10623-6a6e-4760-a206-40894c7c0b1a","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/21d10623-6a6e-4760-a206-40894c7c0b1a_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6},{"id":"https://genegraph.clinicalgenome.org/r/df6ef7e2-28ea-49a6-ad0a-c602c0fcf1a8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df6ef7e2-28ea-49a6-ad0a-c602c0fcf1a8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343981","rdfs:label":"Gorcenco Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":35,"allele":{"id":"https://genegraph.clinicalgenome.org/r/12c03460-4099-4abc-a713-c3b7b2a9fb08","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.968T>C (p.Leu323Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4938321"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Weak deep tendon reflexes. Balance and gait impairment developed in childhood and deteriorated progressively. \n","phenotypes":["obo:HP_0012714","obo:HP_0000648","obo:HP_0001260","obo:HP_0001271","obo:HP_0010871"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4b4bff0e-d39d-461d-96cb-a6b48e221e73_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30343981","allele":{"id":"https://genegraph.clinicalgenome.org/r/12c03460-4099-4abc-a713-c3b7b2a9fb08"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/4b4bff0e-d39d-461d-96cb-a6b48e221e73","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4b4bff0e-d39d-461d-96cb-a6b48e221e73_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/d578870b-0843-48ee-9d87-cb759dba37c9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d578870b-0843-48ee-9d87-cb759dba37c9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31064337","rdfs:label":"Shi Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/42b170da-f5a9-4f97-a2e8-2d7d3933c2f8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.1024dup (p.Leu342ProfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA586162174"}},{"id":"https://genegraph.clinicalgenome.org/r/a5191f60-a3e9-4558-abdf-6bf6ab6fa55a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.1328G>A (p.Cys443Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA372630522"}}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Progressive mental regression and breath holding\n","phenotypes":["obo:HP_0033044","obo:HP_0030319","obo:HP_0002015","obo:HP_0011476"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8a049d57-7c74-4bbe-b891-dcf374441bad_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31064337","allele":{"id":"https://genegraph.clinicalgenome.org/r/a5191f60-a3e9-4558-abdf-6bf6ab6fa55a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/436e62a4-e0dd-4626-82f1-4c134982318f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31064337","allele":{"id":"https://genegraph.clinicalgenome.org/r/42b170da-f5a9-4f97-a2e8-2d7d3933c2f8"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/436e62a4-e0dd-4626-82f1-4c134982318f","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/436e62a4-e0dd-4626-82f1-4c134982318f_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/8a049d57-7c74-4bbe-b891-dcf374441bad","type":"EvidenceLine","dc:description":"Recurrent variant that has already been scored.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a049d57-7c74-4bbe-b891-dcf374441bad_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/63cda020-e415-4929-870f-2bd94152cc01_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63cda020-e415-4929-870f-2bd94152cc01","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29961509","rdfs:label":"Woodcock Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":3,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d3b41914-7e3e-451e-a82f-dc69361bf4f6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001363118.2(SLC52A2):c.505C>T (p.Arg169Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA207764"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Impaired speech.\nMild bilateral flexible pes cavus, and appendicular and axial hypotonia. \nDistal muscle wasting and weakness in the upper limbs.  \n","phenotypes":["obo:HP_0000407","obo:HP_0000648"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8fd1a4fd-f105-4396-ba43-cb7d58b0325a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29961509","allele":{"id":"https://genegraph.clinicalgenome.org/r/d3b41914-7e3e-451e-a82f-dc69361bf4f6"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/8fd1a4fd-f105-4396-ba43-cb7d58b0325a","type":"EvidenceLine","calculatedScore":0.2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8fd1a4fd-f105-4396-ba43-cb7d58b0325a_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/80bb0d0a-5a5a-47f0-b540-cbddc93f49a8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80bb0d0a-5a5a-47f0-b540-cbddc93f49a8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","rdfs:label":"AP1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":7,"allele":{"id":"https://genegraph.clinicalgenome.org/r/84639304-886f-420a-bb08-c522addd961a"},"detectionMethod":"screened for SLC52A2, SLC52A1 and SLC52A3 variants","phenotypeFreeText":"hypotonic","phenotypes":["obo:HP_0007141","obo:HP_0000648"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/97e416de-88f9-4c76-9498-fbe90909813c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29053833","allele":{"id":"https://genegraph.clinicalgenome.org/r/84639304-886f-420a-bb08-c522addd961a"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/97e416de-88f9-4c76-9498-fbe90909813c","type":"EvidenceLine","dc:description":"Recurrent variant that has already been scored.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97e416de-88f9-4c76-9498-fbe90909813c_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/97e416de-88f9-4c76-9498-fbe90909813c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"3 H-Riboflavin uptake assay demonstrated decreased 3 H-riboflavin transport activity by mutated SLC52A2 compared to wild-type (Console et al., 2021, PMID: 34428344).","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/5a500078-4cd5-49db-b22e-c5628ee07304_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a500078-4cd5-49db-b22e-c5628ee07304_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2882ec76-4b6d-40a9-a4b1-e0c40b4da3f3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/573a7caa-6d27-415a-8ca3-5bc2b780bce0","type":"Finding","dc:description":"Quantitative RT-PCR was used to compare mRNA levels of SLC52A2 transcripts in patient cells to healthy controls (methods in supplement). Expression was significantly reduced in patient's fibroblasts. Western blot was performed on cell extracts of patient fibroblasts. hRFT3 protein, the product of SLC52A2, was undetectable in patient cells. Immunohistochemistry in patient fibroblasts showed expected cytoplasmic and endosomal vesicular distribution, as well as reduced protein content of hRFT3 and hRFT1. Mutant cells were derived from patient in Ciccolella1 case. This group found a lack of hRFT1 protein, which is the product of SLC52A1, as well as hRFT3 by western blot and immunolocalization. More research is needed to establish if SLC52A1 is involved in BVVL","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23243084","rdfs:label":"Ciccolella Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0573ff02-2929-4875-9c9a-b85e67f992e0","type":"EvidenceLine","dc:description":"First paper to demonstrate SLC52A2 acts as a riboflavin transporter","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78c0bd2e-2642-4d99-bdc4-dc1730fb6c13","type":"Finding","dc:description":"It is well documented in the literature that three solute carrier family 52 members (SLC52) A1, A2 and A3 are required for riboflavin absorption.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20463145","rdfs:label":"Yao Function","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5a500078-4cd5-49db-b22e-c5628ee07304_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9577e983-7e06-4a2b-b88e-e3c647b899cc","type":"EvidenceLine","dc:description":"In the recuration this was repurposed in the genetic evidence section as functional support for the missense variants.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a6571d9-6b43-4587-b1dc-731c6a32207e","type":"FunctionalAlteration","dc:description":"Riboflavin uptake was 250 fmol/mg less than wildtype","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22864630","rdfs:label":"Haack Nonpatient Cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/dceee4e8-3a59-4809-9513-7cc977f9659e","type":"EvidenceLine","dc:description":"In the recuration this was repurposed in the genetic evidence section as functional support for the missense variants.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c47af42e-2ce6-4c3a-98db-275252e63bcb","type":"FunctionalAlteration","dc:description":"Uptake in 5/7 mutants was completely abolished, while uptake in the two other mutants showed a moderate but significant decrease in activity compared to WT. Western blot of transfected cells showed decreased expression of SLC52A2 in all mutants but one.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24253200","rdfs:label":"Foley Nonpatient Cells"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4aa3a8e1-e4c8-438f-bb22-fa1ddd5bf8a0","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1854f3a9-b585-4c2d-87c3-895750235d3f","type":"FunctionalAlteration","dc:description":"Significance of difference is only provided for one out of four time points.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23243084","rdfs:label":"Ciccolella Patient Cells"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2}],"evidenceStrength":"Definitive","sequence":7045,"specifiedBy":"GeneValidityCriteria9","strengthScore":14,"subject":{"id":"https://genegraph.clinicalgenome.org/r/iJDSLC61jeE","type":"GeneValidityProposition","disease":"obo:MONDO_0013867","gene":"hgnc:30224","modeOfInheritance":"obo:HP_0000007"},"version":"2.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_5a500078-4cd5-49db-b22e-c5628ee07304-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}